Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Neuroscience: Improving Translation of Animal Models for Nervous System Disorders: A Workshop
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
12th International Conference on Myasthenia Gravis and Related Disorders
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
European School of Neuroimmunology 15th Course
Brain and BrainPET 2015
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
MSGene
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
AAN: Annual Meeting On Demand Encore: Treatment Optimization for Relapsing MS
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
Avonex approval application
Effirma, Synthetic Biologics
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Multiple sclerosis: pathogenesis and treatment.
Influence of infection on exacerbations of multiple sclerosis.

Pages